![Nathan Pennell: EGFR mutation testing, treatment and survival in stage I–III NSCLC](https://oncodaily.com/pub/uploads/2024/01/Nathan-A.-Pennell-e1704995996241.png)
Photo from Nathan A. Pennell/X
Jun 29, 2024, 08:58
Nathan Pennell: EGFR mutation testing, treatment and survival in stage I–III NSCLC
Nathan Pennell, Professor and Vice Chair of Clinical Research at Cleveland Clinic, shared on X: .
“Happy to see our paper out led by Bharathi Muthusamy.
EGFR mutation testing, treatment and survival in stage I–III non-small-cell lung cancer: CancerLinQ Discovery database retrospective analysis.”
Proceed to the article.
Source: Nathan Pennell/X